Marie Bleakley, MD, PhD, on GVHD: Reducing Rates and Increasing Survival

2016 ASH Annual Meeting & Exposition
Tweet this page

Marie Bleakley, MD, PhD, of Fred Hutchinson Cancer Research Center, discusses data on using naive T-cell depletion of peripheral blood stem cells, which led to very low rates of chronic graft-vs-host-disease and high survival (Abstract 668).

Advertisement

Advertisement



Advertisement

click me